91832-40-5 | (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
1g	≥ 94% (Assay on anhydrous basis)	in stock	$62.00	$43.00
5g	≥ 94% (Assay on anhydrous basis)	in stock	$155.00	$108.00
10g	95%	in stock	$277.00	$194.00
25g	≥ 94% (Assay on anhydrous basis)	in stock	$512.00	$358.00

Description

• Catalog Number: AI61510
• Chemical Name: (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• CAS Number: 91832-40-5
• Molecular Formula: C14H13N5O5S2
• Molecular Weight: 395.4135
• MDL Number: MFCD28900275
• SMILES: O/N=C(/c1csc(n1)N)\C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)C=C
• NSC Number: 758926

Computed Properties

• Complexity: 739
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Defined Bond Stereocenter Count: 1
• Heavy Atom Count: 26
• Hydrogen Bond Acceptor Count: 10
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 5

Literature

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media.

  Drugs 20121022

• Development and validation of a rapid HPLC method for the determination of cefdinir in beagle dog plasma integrated with an automatic on-line solid-phase extraction following protein precipitation in the 96-well plate format.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501

• [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].

  Yao xue xue bao = Acta pharmaceutica Sinica 20120401

• Bioequivalence evaluation of cefdinir in healthy fasting subjects.

  Arzneimittel-Forschung 20120101

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Simultaneous determination of cefdinir and cefixime in human plasma by RP-HPLC/UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110815

• Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.

  Scandinavian journal of infectious diseases 20110801

• Prophylactic cefdinir for pediatric cases of complicated urinary tract infection.

  Pediatrics international : official journal of the Japan Pediatric Society 20110201

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.

  International journal of pharmaceutics 20100830

• Another vacation, another medical 'crisis'.

  Nature reviews. Gastroenterology & hepatology 20100401

• In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.

  The Japanese journal of antibiotics 20100201

• Infant male with blood-colored stools.

  Annals of emergency medicine 20090801

• Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir.

  International journal of pediatric otorhinolaryngology 20090501

• Visual diagnosis: four infants who have red, 'bloody' stools.

  Pediatrics in review 20090401

• Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use.

  Journal of general internal medicine 20081101

• Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080801

• Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.

  Journal of pharmaceutical and biomedical analysis 20080715

• Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas.

  Pharmacotherapy 20080501

• A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder.

  Journal of paediatrics and child health 20080401

• Voltammetric behavior of cefdinir in solubilized system.

  Journal of colloid and interface science 20080215

• Cefdinir-associated 'bloody stools' in an infant.

  Journal of the American Board of Family Medicine : JABFM 20080101

• Comparative bioavailability of two cefdinir suspension formulations in Middle Eastern healthy volunteers after single oral administration.

  Arzneimittel-Forschung 20080101

• Effect of L-phenylalanine supplementation and a high-protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study.

  Journal of clinical pharmacy and therapeutics 20070601

• Isolation, structural elucidation and characterization of impurities in Cefdinir.

  Journal of pharmaceutical and biomedical analysis 20070312

• Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.

  Expert review of anti-infective therapy 20070201

• Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.

  Journal of biopharmaceutical statistics 20070101

• Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.

  Current medical research and opinion 20061201

• Therapeutic experience with cefdinir in the treatment of uSSSIs.

  International journal of clinical practice 20061001

• Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20061001

• Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.

  Current medical research and opinion 20060901

• Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?

  Diagnostic microbiology and infectious disease 20060801

• The efficacy of cefdinir in acute bacterial rhinosinusitis.

  Expert opinion on pharmacotherapy 20060601

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Selective method for the determination of cefdinir in human plasma using liquid chromatography electrospray ionization tandam mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060413

• Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.

  The Pediatric infectious disease journal 20060301

• A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.

  The Pediatric infectious disease journal 20060301

• Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.

  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20060101

• Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid.

  Pharmacotherapy 20051201

• A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.

  Clinical therapeutics 20051201

• Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.

  Biochemical pharmacology 20051001

• Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora.

  Archives of otolaryngology--head & neck surgery 20050901

• A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.

  Clinical therapeutics 20050801

• Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate.

  Journal of medical microbiology 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.

  Clinical therapeutics 20050601

• Cefdinir: an oral alternative to parenteral cephems.

  Diagnostic microbiology and infectious disease 20050401

• [Effects of cefdinir in pediatric infectious diseases].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20050301

• Estimation of the intervention effect in a non-randomized study with pre- and post-mismeasured binary responses.

  Statistics in medicine 20050215

• Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections.

  International journal of antimicrobial agents 20050101

• Determination of Cefdinir by a stability-indicating liquid chromatographic method.

  Journal of AOAC International 20050101

• Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.

  Clinical therapeutics 20041201

• [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].

  Zhonghua yi xue za zhi 20041117

• [Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].

  Zhonghua yi xue za zhi 20041117

• Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media.

  The Pediatric infectious disease journal 20040901

• [In vitro antibacterial activity of cefdinir against isolates of respiratory tract pathogens in children].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20040901

• Fungal biofilm formation on cochlear implant hardware after antibiotic-induced fungal overgrowth within the middle ear.

  The Pediatric infectious disease journal 20040801

• Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.

  Diagnostic microbiology and infectious disease 20040801

• Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.

  Cutis 20040501

• Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.

  Biological & pharmaceutical bulletin 20040101

• Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.

  Drugs 20040101

• Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions.

  Paediatric drugs 20040101

• Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).

  Diagnostic microbiology and infectious disease 20031101

• [Clinical efficacy and bacteriological studies of clarithromycin and cefdinir against group A beta-hemolytic streptococcal tonsillopharyngitis].

  The Japanese journal of antibiotics 20030801

• An alternative procedure for preparation of cefdinir.

  Farmaco (Societa chimica italiana : 1989) 20030601

• [Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].

  The Japanese journal of antibiotics 20030601

• Management update of acute bacterial rhinosinusitis and the use of cefdinir.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20021201

• [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].

  The Japanese journal of antibiotics 20021201

• [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].

  The Japanese journal of antibiotics 20021201

• Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.

  Clinical therapeutics 20020401

• Transporter-mediated Drug Interactions.

  Drug metabolism and pharmacokinetics 20020101

• Antibacterial action of several tannins against Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20011001

• Evaluation of oral antimicrobial agent levels in tooth extraction sites.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20010601

• [Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (5)--Six-month repeated oral dose toxicity study and supplement study in rats].

  The Journal of toxicological sciences 20010501

• Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20010301

• Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure.

  Internal medicine (Tokyo, Japan) 20010201

• beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.

  The Journal of biological chemistry 20000121

• Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells.

  The American journal of physiology 19971101

• Interaction of anionic cephalosporins with the intestinal and renal peptide transporters PEPT 1 and PEPT 2.

  Biochimica et biophysica acta 19970313

• Effect of estrogen administration on activities of testosterone 5alpha-reductase, alkaline phosphatase and arginase in the ventral and the dorsolateral prostates of rats.

  Endocrinologia japonica 19750801